These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 1319000

  • 1. Detection of functional ovarian hyperandrogenism in women with androgen excess.
    Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z.
    N Engl J Med; 1992 Jul 16; 327(3):157-62. PubMed ID: 1319000
    [Abstract] [Full Text] [Related]

  • 2. Source localization of androgen excess in adolescent girls.
    Ibáñez L, Potau N, Zampolli M, Prat N, Gussinyé M, Saenger P, Vicens-Calvet E, Carrascosa A.
    J Clin Endocrinol Metab; 1994 Dec 16; 79(6):1778-84. PubMed ID: 7989484
    [Abstract] [Full Text] [Related]

  • 3. Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.
    Bidzińska B, Tworowska U, Demissie M, Milewicz A.
    Przegl Lek; 2000 Dec 16; 57(7-8):393-6. PubMed ID: 11109312
    [Abstract] [Full Text] [Related]

  • 4. Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism.
    Rosenfield RL, Barnes RB, Ehrmann DA.
    J Clin Endocrinol Metab; 1994 Dec 16; 79(6):1686-92. PubMed ID: 7989476
    [Abstract] [Full Text] [Related]

  • 5. Gonadotropin-releasing hormone agonist as a probe for the pathogenesis and diagnosis of ovarian hyperandrogenism.
    Rosenfield RL, Ehrmann DA, Barnes RB, Sheikh Z.
    Ann N Y Acad Sci; 1993 May 28; 687():162-81. PubMed ID: 8323171
    [Abstract] [Full Text] [Related]

  • 6. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome.
    Barnes RB, Rosenfield RL, Burstein S, Ehrmann DA.
    N Engl J Med; 1989 Mar 02; 320(9):559-65. PubMed ID: 2521688
    [Abstract] [Full Text] [Related]

  • 7. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency.
    Barnes RB, Ehrmann DA, Brigell DF, Rosenfield RL.
    J Clin Endocrinol Metab; 1993 Feb 02; 76(2):450-5. PubMed ID: 8381802
    [Abstract] [Full Text] [Related]

  • 8. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS, Thompson DL.
    J Clin Endocrinol Metab; 1990 Apr 02; 70(4):1096-102. PubMed ID: 2156885
    [Abstract] [Full Text] [Related]

  • 9. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women.
    Barnes RB, Rosenfield RL, Ehrmann DA, Cara JF, Cuttler L, Levitsky LL, Rosenthal IM.
    J Clin Endocrinol Metab; 1994 Nov 02; 79(5):1328-33. PubMed ID: 7962325
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of nonclassic adrenal hyperplasia (NCAH) in hyperandrogenic women.
    Fanta M, Cibula D, Vrbíková J.
    Gynecol Endocrinol; 2008 Mar 02; 24(3):154-7. PubMed ID: 18335331
    [Abstract] [Full Text] [Related]

  • 11. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
    Pasquali R, Patton L, Pocognoli P, Cognigni GE, Gambineri A.
    J Clin Endocrinol Metab; 2007 Nov 02; 92(11):4208-17. PubMed ID: 17785360
    [Abstract] [Full Text] [Related]

  • 12. Ultrasonographic appearance of polycystic ovaries is associated with exaggerated ovarian androgen and oestradiol responses to gonadotrophin-releasing hormone agonist in women undergoing assisted reproduction treatment.
    Suikkari AM, MacLachlan V, Montalto J, Calderon I, Healy DL, McLachlan RI.
    Hum Reprod; 1995 Mar 02; 10(3):513-9. PubMed ID: 7782424
    [Abstract] [Full Text] [Related]

  • 13. Treatment of hirsutism with a gonadotropin-releasing hormone agonist (nafarelin).
    Andreyko JL, Monroe SE, Jaffe RB.
    J Clin Endocrinol Metab; 1986 Oct 02; 63(4):854-9. PubMed ID: 2943756
    [Abstract] [Full Text] [Related]

  • 14. Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome.
    White D, Leigh A, Wilson C, Donaldson A, Franks S.
    Clin Endocrinol (Oxf); 1995 May 02; 42(5):475-81. PubMed ID: 7621565
    [Abstract] [Full Text] [Related]

  • 15. Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease.
    Toscano V, Balducci R, Bianchi P, Mangiantini A, Sciarra F.
    J Clin Endocrinol Metab; 1990 Aug 02; 71(2):288-92. PubMed ID: 2166066
    [Abstract] [Full Text] [Related]

  • 16. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism.
    Carmina E, Rosato F, Jannì A, Rizzo M, Longo RA.
    J Clin Endocrinol Metab; 2006 Jan 02; 91(1):2-6. PubMed ID: 16263820
    [Abstract] [Full Text] [Related]

  • 17. Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Ghizzoni L, Virdis R, Vottero A, Cappa M, Street ME, Zampolli M, Ibañez L, Bernasconi S.
    J Clin Endocrinol Metab; 1996 Feb 02; 81(2):601-6. PubMed ID: 8636275
    [Abstract] [Full Text] [Related]

  • 18. Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine-metabolic and ultrasonographic differences.
    Falsetti L, Gambera A, Andrico S, Sartori E.
    Gynecol Endocrinol; 2002 Aug 02; 16(4):275-84. PubMed ID: 12396556
    [Abstract] [Full Text] [Related]

  • 19. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome.
    Gonzalez F, Hatala DA, Speroff L.
    Am J Obstet Gynecol; 1991 Sep 02; 165(3):535-45. PubMed ID: 1832519
    [Abstract] [Full Text] [Related]

  • 20. The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
    Pall M, Azziz R, Beires J, Pignatelli D.
    Fertil Steril; 2010 Jul 02; 94(2):684-9. PubMed ID: 19726039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.